CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+5.2%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.04B
AUM Growth
+$1.04B
(-0.12%)
Cap. Flow
-$53.5M
Cap. Flow
% of AUM
-5.13%
Top 10 Holdings %
Top 10 Hldgs %
55.95%
Holding
45
New
9
Increased
11
Reduced
13
Closed
6
Top Buys
| 1 |
Haemonetics
HAE
|
$39.2M |
| 2 |
Labcorp
LH
|
$36.8M |
| 3 |
Community Health Systems
CYH
|
$29.4M |
| 4 |
Tenet Healthcare
THC
|
$25.7M |
| 5 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$23.1M |
Top Sells
| 1 |
Viatris
VTRS
|
$73.2M |
| 2 |
Merck
MRK
|
$49.6M |
| 3 |
UnitedHealth
UNH
|
$28.7M |
| 4 |
Agilent Technologies
A
|
$28.6M |
| 5 |
HCA Healthcare
HCA
|
$23.6M |
Sector Composition
| 1 | Healthcare | 87.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $87.2M | 6.83% | 1,650,000 -350,000 | -18% | -$18.5M |
|
2
Elevance Health
ELV
$71.8B
| $79.6M | 6.24% | 800,000 | – | – |
|
|
3
Tenet Healthcare
THC
$16.3B
| $72.8M | 5.7% | 1,700,000 +600,000 | +55% | +$25.7M |
|
4
Quest Diagnostics
DGX
$20.3B
| $63.7M | 4.99% | 1,100,000 +300,000 | +38% | +$17.4M |
|
5
CONMED
CNMD
$1.68B
| $60.2M | 4.72% | 1,385,000 | – | – |
|
|
6
Community Health Systems
CYH
$387M
| $49M | 3.84% | 1,250,000 +750,000 | +150% | +$29.4M |
|
|
VOLC
7
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $48.3M | 3.78% | 2,450,000 +100,000 | +4% | +$1.97M |
|
|
8
HCA Healthcare
HCA
$94.5B
| $42M | 3.29% | 800,000 -450,000 | -36% | -$23.6M |
|
|
MNK
9
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $41.2M | 3.23% | 650,000 -350,000 | -35% | -$22.2M |
|
|
10
Haemonetics
HAE
$2.63B
| $39.2M | 3.07% | +1,202,000 | New | +$39.2M |
|
|
11
Labcorp
LH
$23.1B
| $36.8M | 2.89% | +375,000 | New | +$36.8M |
|
12
Masimo
MASI
$7.59B
| $34.8M | 2.73% | 1,275,000 -150,000 | -11% | -$4.1M |
|
13
Hologic
HOLX
$14.9B
| $32.3M | 2.53% | 1,500,000 | – | – |
|
|
UAM
14
DELISTED
Universal American Corp
UAM
| $29.5M | 2.32% | 4,178,259 +1,678,259 | +67% | +$11.9M |
|
|
15
UnitedHealth
UNH
$281B
| $24.6M | 1.93% | 300,000 -350,000 | -54% | -$28.7M |
|
|
ARIA
16
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $24.2M | 1.89% | 3,000,000 -2,250,000 | -43% | -$18.1M |
|
|
HRC
17
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $23.1M | 1.81% | +600,000 | New | +$23.1M |
|
18
Abbott
ABT
$231B
| $23.1M | 1.81% | +600,000 | New | +$23.1M |
|
19
Humana
HUM
$36.5B
| $22.5M | 1.77% | 200,000 -200,000 | -50% | -$22.5M |
|
|
KERX
20
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $21.3M | 1.67% | +1,250,000 | New | +$21.3M |
|
|
AMRN
21
Amarin Corp
AMRN
$311M
| $19.9M | 1.56% | 11,000,000 +2,500,000 | +29% | +$4.53M |
|
|
GHDX
22
DELISTED
Genomic Health, Inc.
GHDX
| $19.8M | 1.55% | +750,000 | New | +$19.8M |
|
|
BLUE
23
DELISTED
bluebird bio
BLUE
| $16.1M | 1.26% | 706,900 +500,000 | +242% | +$11.4M |
|
|
FURX
24
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $13.1M | 1.02% | +150,000 | New | +$13.1M |
|
|
TRNX
25
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $13M | 1.02% | 613,655 +363,655 | +145% | +$7.72M |
|